170 related articles for article (PubMed ID: 36765520)
1. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.
Han L; Dai W; Luo W; Ye L; Fang H; Mo S; Li Q; Xu Y; Wang R; Cai G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765520
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
4. FASN promotes gallbladder cancer progression and reduces cancer cell sensitivity to gemcitabine through PI3K/AKT signaling.
Cheng H; Sun Y; Yu X; Zhou D; Ding J; Wang S; Ma F
Drug Discov Ther; 2023 Nov; 17(5):328-339. PubMed ID: 37743521
[TBL] [Abstract][Full Text] [Related]
5. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
Zaytseva YY; Rychahou PG; Le AT; Scott TL; Flight RM; Kim JT; Harris J; Liu J; Wang C; Morris AJ; Sivakumaran TA; Fan T; Moseley H; Gao T; Lee EY; Weiss HL; Heuer TS; Kemble G; Evers M
Oncotarget; 2018 May; 9(37):24787-24800. PubMed ID: 29872506
[TBL] [Abstract][Full Text] [Related]
7. The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.
Papaevangelou E; Almeida GS; Box C; deSouza NM; Chung YL
Int J Cancer; 2018 Aug; 143(4):992-1002. PubMed ID: 29569717
[TBL] [Abstract][Full Text] [Related]
8. PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway.
Liu W; Tang J; Gao W; Sun J; Liu G; Zhou J
Cancer Cell Int; 2024 Mar; 24(1):90. PubMed ID: 38429738
[TBL] [Abstract][Full Text] [Related]
9. High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway.
Yang T; Qiao S; Zhu X
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14169-14183. PubMed ID: 37553421
[TBL] [Abstract][Full Text] [Related]
10.
Tadros S; Shukla SK; King RJ; Gunda V; Vernucci E; Abrego J; Chaika NV; Yu F; Lazenby AJ; Berim L; Grem J; Sasson AR; Singh PK
Cancer Res; 2017 Oct; 77(20):5503-5517. PubMed ID: 28811332
[TBL] [Abstract][Full Text] [Related]
11. FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.
Ni J; Shang Y; Wang WD; Wang C; Wang AM; Li GJ; Chen SZ
Curr Mol Pharmacol; 2023; 16(7):771-786. PubMed ID: 36411574
[TBL] [Abstract][Full Text] [Related]
12. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
Sankaranarayanapillai M; Zhang N; Baggerly KA; Gelovani JG
Mol Imaging Biol; 2013 Apr; 15(2):136-47. PubMed ID: 22886728
[TBL] [Abstract][Full Text] [Related]
13. Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway.
Ye M; Lu F; Chen J; Yu P; Xu Y; He N; Hu C; Zhong Y; Yan L; Gu D; Xu L; Bai J; Tian Y; Tang Q
J Cancer; 2023; 14(8):1458-1469. PubMed ID: 37283794
[No Abstract] [Full Text] [Related]
14. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
[TBL] [Abstract][Full Text] [Related]
15. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
16. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway.
Lu T; Sun L; Wang Z; Zhang Y; He Z; Xu C
Onco Targets Ther; 2019; 12():3339-3347. PubMed ID: 31118685
[No Abstract] [Full Text] [Related]
18. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
Ross J; Najjar AM; Sankaranarayanapillai M; Tong WP; Kaluarachchi K; Ronen SM
Mol Cancer Ther; 2008 Aug; 7(8):2556-65. PubMed ID: 18723500
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation.
Zhang C; Zhang Y; Dong Y; Zi R; Wang Y; Chen Y; Liu C; Wang J; Wang X; Li J; Liang H; Ou J
Cell Death Discov; 2024 Jan; 10(1):41. PubMed ID: 38263401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
